While antitumor immune components, including cytotoxic CD8+ T cells, infiltrate the early premalignant stages of IPMN lesions, they are progressively lost during tumor progression to PDAC, accompanied by the concomitant accumulation of immunosuppressive cells [6–8]. Here, CD8A is linked to neoplasm.